Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IMU-935 |
Synonyms | |
Therapy Description |
Limited information is currently available on IMU-935, a putative inverse agonist of the transcription factor RORgamma truncated (Dec 2022). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMU-935 | IMU 935|IMU935 | Limited information is currently available on IMU-935, a putative inverse agonist of the transcription factor RORgamma truncated (Dec 2022). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05124795 | Phase I | IMU-935 | IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer | Terminated | GBR | 0 |